CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.
Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.
CorMedix appoints director
Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection
Japan M&A By the Numbers: Q4 2023
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.
Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.